Premium
Letter: overcoming secondary loss of response to infliximab—it is not the drug, it is how you use it!
Author(s) -
Langenberg Daniel R.,
Vasudevan Abhinav
Publication year - 2018
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.14959
Subject(s) - medicine , infliximab , drug , pharmacology , tumor necrosis factor alpha
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom